enVVeno Medical (NVNO) Operating Income (2017 - 2026)

enVVeno Medical has reported Operating Income for 10 years, with the latest figure at -$3.8 million in Q2 2026.

• On a quarterly basis, Operating Income rose 46.15% year-over-year to -$3.8 million in Q2 2026; TTM through Jun 2026 was -$16.8 million, a 32.64% increase from a year earlier, with the FY2025 full-year figure at -$20.9 million, up 12.28% from the prior year.
• Operating Income was -$3.8 million for Q2 2026 at enVVeno Medical, up from -$4.1 million in the prior quarter.
• The five-year high for Operating Income was -$3.8 million in Q2 2026, with the low at -$7.0 million in Q2 2025.
• Average Operating Income over 5 years is -$5.7 million, with a median of -$5.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Operating Income tumbled 192.79% in 2022, then surged 46.15% in 2026.
• Over 5 years, Operating Income stood at -$6.5 million in 2022, then rose by 2.82% to -$6.3 million in 2023, then dropped by 6.71% to -$6.7 million in 2024, then soared by 40.1% to -$4.0 million in 2025, then climbed by 5.41% to -$3.8 million in 2026.
• The last three Operating Income figures came in at -$3.8 million (Q2 2026), -$4.1 million (Q1 2026), and -$4.0 million (Q4 2025), per Business Quant data.